Clinical Trial Update: Belinostat, Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Cancer of Unknown Primary [Phase 2]

View source ↗

Summary

Phase 2 trial comparing Belinostat, Carboplatin and Paclitaxel (BelCaP) to Carboplatin and Paclitaxel in carcinoma of unknown primary has completed enrollment, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoma of Unknown Primary

Drugs mentioned

• Belinostat (belinostat)
• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Valerio Therapeutics | Conditions: Carcinoma of Unknown Primary | Phase 2 | Status: COMPLETED | Results posted: 2014-12-09